☆ 4.7 Review

Efficacy and safety of Shexiang Baoxin Pill for stable coronary artery disease: A systematic review and meta-analysis of 42 randomized controlled trials

FRONTIERS IN PHARMACOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Public, Environmental & Occupational Health

Strategies comparison in response to the two waves of COVID-19 in the United States and India

Junyan Yang et al.

Summary: This study compares the prevention and control strategies adopted by the United States and India in the COVID-19 outbreak and finds differences between the two countries. India's containment strategies helped control the epidemic in the early stage, but various factors led to a severe situation. The United States, while employing mitigation strategies, did not achieve ideal results.

INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Traditional Chinese Medicine for Coronary Artery Disease Treatment: Clinical Evidence From Randomized Controlled Trials

Bo Liang et al.

Summary: Traditional Chinese medicine has a long history and is widely used in clinical practice, but its role in the prevention and treatment of coronary artery disease remains unclear due to lack of scientific evidence. Randomized controlled trials have shown that traditional Chinese medicine can be used as a complementary method in managing coronary artery disease, with similar safety profile to conventional medications. Further research with long-term endpoints is needed to fully assess its safety and efficacy.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Revascularization versus medical therapy for the treatment of stable coronary artery disease: A meta-analysis of contemporary randomized controlled trials

Jari A. Laukkanen et al.

Summary: A systematic review and meta-analysis showed that among stable coronary artery disease patients, revascularization plus medical therapy did not offer a survival advantage beyond medical therapy alone, but could reduce the overall risk of combined outcomes including mortality, myocardial infarction, revascularizations, rehospitalizations, or stroke.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial

Jun-Bo Ge et al.

Summary: The study aimed to determine the effects of MUSKARDIA in stable CAD patients. The results showed that as an add-on to optimal medical therapy, MUSKARDIA significantly reduced angina frequency and showed a trend towards reducing major adverse cardiovascular events in stable CAD patients, with similar rates of adverse events between the MUSKARDIA and placebo groups.

CHINESE MEDICAL JOURNAL (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Shexiang Baoxin Pill Attenuates Ischemic Injury by Promoting Angiogenesis by Activation of Aldehyde Dehydrogenase 2

Jingjing Hu et al.

Summary: The study showed that SBP protects against ischemic injury in lower limbs through the ALDH2-dependent pathway, and its protective mechanism in cardiovascular microvascular endothelial cells is partly mediated through the ALDH2/AKT/mammalian target of rapamycin pathways.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2021)

添加到收藏夹

Review Integrative & Complementary Medicine

Efficacy and Safety of Shexiang Baoxin Pill for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis

Jingjing Wei et al.

Summary: The study indicates that the combination of Shexiang Baoxin Pill (SBP) with conventional western medicine for the treatment of coronary heart disease (CHD) after percutaneous coronary intervention (PCI) significantly reduces major adverse cardiac events (MACE), improves left ventricular ejection fraction (LVEF), and lowers N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) levels. Furthermore, SBP also mediates inflammatory mediators and blood lipid index, without increasing the incidence of adverse reactions. However, further standardized, rigorous, high-quality clinical trials are needed to verify these conclusions due to limitations in the quantity and quality of eligible studies.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2021)

添加到收藏夹

Review Cell Biology

Shexiang Baoxin Pill for Acute Myocardial Infarction: Clinical Evidence and Molecular Mechanism of Antioxidative Stress

Jianbo Guo et al.

Summary: The study evaluated the effectiveness and safety of Shexiang Baoxin Pill (SBP) for acute myocardial infarction (AMI) and found that SBP was effective in improving clinical symptoms, cardiac function, oxidative stress, and inflammatory responses. Laboratory findings confirmed that SBP can enhance the activity of endothelial nitric oxide synthase and have adjunctive effects on AMI through antioxidative stress mechanisms.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Effects of Shexiang Baoxin Pill for Coronary Microvascular Function: A Systematic Review and Meta-Analysis

Mengxi Wang et al.

Summary: This study aimed to evaluate the effects of Shexiang Baoxin Pill on coronary microvascular function. The meta-analysis of eleven studies showed that the combination of Shexiang Baoxin Pill and conventional treatment can improve coronary flow reserve (CFR), decrease microvascular resistance index (IMR), increase serum nitric oxide (NO), and reduce serum hypersensitive C-reactive protein (hs-CRP) levels. However, more high-quality clinical studies are needed to further verify the efficacy and safety of this drug.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Health Care Sciences & Services

A systematic review and meta-analysis of clinical research on treating angina pectoris of coronary heart disease with traditional Chinese medicine to promote blood circulation and remove blood stasis

Wen Chen et al.

Summary: This study aimed to explore the therapeutic effect of traditional Chinese medicine (TCM) in the treatment of angina pectoris of coronary heart disease (CHD) through a literature search and meta-analysis. The results showed that compared with conventional Western medicine, TCM + conventional Western medicine had a better efficacy in treating angina pectoris with lower occurrence of adverse events.

ANNALS OF PALLIATIVE MEDICINE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Mechanism of angiogenesis promotion with Shexiang Baoxin Pills by regulating function and signaling pathway of endothelial cells through macrophages

Jiange Zhang et al.

ATHEROSCLEROSIS (2020)

添加到收藏夹

Review Medicine, General & Internal

Compound salvia pellet might be more effective and safer for chronic stable angina pectoris compared with nitrates A systematic review and meta-analysis of randomized controlled trials

Wei Huiping et al.

MEDICINE (2019)

添加到收藏夹

Article Cell Biology

Shexiang Baoxin Pill Alleviates the Atherosclerotic Lesions in Mice via Improving Inflammation Response and Inhibiting Lipid Accumulation in the Arterial Wall

Li Lu et al.

MEDIATORS OF INFLAMMATION (2019)

添加到收藏夹

Review Chemistry, Medicinal

Corn silk decoction for blood lipid in patients with angina pectoris: A systematic review and meta-analysis

Shihua Shi et al.

PHYTOTHERAPY RESEARCH (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study

Leonardo De Luca et al.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2019)

添加到收藏夹

Article Multidisciplinary Sciences

A network-based method for mechanistic investigation of Shexiang Baoxin Pill's treatment of cardiovascular diseases

Hai-Yang Fang et al.

SCIENTIFIC REPORTS (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Executive Summary: Heart Disease and Stroke Statistics-2016 Update A Report From the American Heart Association

Dariush Mozaffarian et al.

CIRCULATION (2016)

添加到收藏夹

Review Integrative & Complementary Medicine

The Effect of Chinese Herbal Medicine Gualouxiebaibanxia Decoction for the Treatment of Angina Pectoris: A Systematic Review

Wei Liu et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2013 ESC guidelines on the management of stable coronary artery disease

Gilles Montalescot et al.

EUROPEAN HEART JOURNAL (2013)

添加到收藏夹

Article Medicine, General & Internal

Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents The OPTIMIZE Randomized Trial

Fausto Feres et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease

Stephan D. Fihn et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)

添加到收藏夹

Article Medicine, General & Internal

Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis

Deepak L. Bhatt et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.